We are live on ! Find out more
IHM

Iguana Healthcare Management Portfolio holdings

AUM $152M
1-Year Est. Return 48.74%
This Fund
S&P 500
This Quarter Est. Return
+8.86%
1 Year Est. Return
+48.74%
3 Year Est. Return
+142.13%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$152M
AUM Growth
-$1.54M
Cap. Flow
+$1.94M
Cap. Flow %
1.28%
Top 10 Hldgs %
37.96%
Holding
86
New
25
Increased
15
Reduced
14
Closed
24

Top Buys

Rank Stock Value
1
ZSAN
Zosano Pharma Corporation
ZSAN
+$4.78M
2
SHPG
Shire pic
SHPG
+$3.44M
3
ALXN
Alexion Pharmaceuticals
ALXN
+$3.29M
4
CNC icon
Centene
CNC
+$3.13M
5
LH icon
Labcorp
LH
+$2.99M

Top Sells

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$7.83M
2
AERI
Aerie Pharmaceuticals
AERI
+$5.08M
3
ABBV icon
AbbVie
ABBV
+$4.84M
4
ESPR
Esperion Therapeutics
ESPR
+$4.77M
5
KTWO
K2M Group Holdings, Inc
KTWO
+$2.97M

Sector Composition

Rank Sector Weight
1 Healthcare 77.97%
2 Energy 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SGEN
51
DELISTED
Seagen Inc. Common Stock
SGEN
$916K 0.6%
+17,500
New +$954K
SPPI
52
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
$805K 0.53%
+50,000
New +$990K
DERM
53
DELISTED
Dermira, Inc.
DERM
$799K 0.53%
100,000
– –
ASMB icon
54
Assembly Biosciences
ASMB
$505M
$737K 0.48%
+1,250
New +$775K
ADMS
55
DELISTED
Adamas Pharmaceuticals
ADMS
$717K 0.47%
+30,000
New +$946K
EXEL icon
56
Exelixis
EXEL
$14.1B
$665K 0.44%
+30,000
New +$829K
AFMD
57
DELISTED
Affimed
AFMD
$555K 0.37%
+30,000
New +$566K
SCYX icon
58
SCYNEXIS
SCYX
$38.9M
$536K 0.35%
5,000
+1,875
+60% +$259K
OMED
59
DELISTED
OncoMed Pharmaceuticals, Inc.
OMED
$477K 0.31%
150,000
– –
KTWO
60
DELISTED
K2M Group Holdings, Inc
KTWO
$474K 0.31%
25,000
-150,000
-86% -$2.97M
MRNS
61
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
$382K 0.25%
25,000
– –
SLDB icon
62
Solid Biosciences
SLDB
$847M
$375K 0.25%
+3,333
New +$1.13M
ABBV icon
63
AbbVie
ABBV
$447B
– –
-50,000
Closed -$4.84M
BSX icon
64
Boston Scientific
BSX
$65.4B
– –
-50,000
Closed -$1.24M
DHR icon
65
Danaher
DHR
$143B
– –
-28,200
Closed -$2.32M
IONS icon
66
Ionis Pharmaceuticals
IONS
$8.84B
– –
-40,000
Closed -$2.01M
PBYI icon
67
Puma Biotechnology
PBYI
$418M
– –
-17,500
Closed -$1.73M
PFE icon
68
Pfizer
PFE
$141B
– –
-52,700
Closed -$1.81M
RGNX icon
69
Regenxbio
RGNX
$574M
– –
-30,000
Closed -$998K
SUPN icon
70
Supernus Pharmaceuticals
SUPN
$2.77B
– –
-50,000
Closed -$1.99M
WVE icon
71
Wave Life Sciences
WVE
$1.11B
– –
-50,000
Closed -$1.75M
ZBH icon
72
Zimmer Biomet
ZBH
$17.4B
– –
-23,175
Closed -$2.71M
LUMO
73
CALL
DELISTED
Lumos Pharma, Inc. Common Stock
LUMO
– –
-5,556
Closed -$406K
ASXC
74
DELISTED
Asensus Surgical, Inc.
ASXC
– –
-9,615
Closed -$241K
LHCG
75
DELISTED
LHC Group LLC
LHCG
– –
-15,000
Closed -$919K
1 2
3
4

Similar funds

HWP
Hefty Wealth Partners Auburn, Indiana $155M AUM 7.56% 1-Year Est. Return
PAM
PineView Asset Management Greenwich, Connecticut $166M AUM 27.74% 1-Year Est. Return
USG2
Union Square GP 2008 New York $172M AUM
LCM
Lee Capital Management New York $132M AUM 21% 1-Year Est. Return
FPF
FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return
FIAS
FinTrust Investment Advisory Services Greenville, South Carolina $109M AUM
CII
Chapter IV Investors Charlotte, North Carolina $109M AUM 9.21% 1-Year Est. Return
OPWM
Oak Point Wealth Management Portage, Michigan $98M AUM

Iguana Healthcare Management's Q1 2018 Portfolio in Review

As of Q1 2018, Iguana Healthcare Management held 86 positions worth $152M, down 1% from $154M the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Iguana Healthcare Management's Q1 2018 filing shows 25 new, 15 increased, 14 reduced and 24 closed positions. Its largest new stake was Zosano Pharma Corporation: 14,286 shares worth $2.52M. The largest sale was Celgene Corp, an estimated $7.83M.

By sector, the portfolio is most concentrated in Healthcare at 78% of assets, down from 82% a quarter earlier, followed by Energy.

  • Iguana Healthcare Management's largest Q1 2018 buy was Zosano Pharma Corporation: 14,286 shares worth $2.52M.
  • Iguana Healthcare Management added most to Arena Pharmaceuticals Inc in Q1 2018, an estimated $1.94M increase.
  • Iguana Healthcare Management's biggest Q1 2018 reduction was Esperion Therapeutics, cutting an estimated $4.77M.
  • Iguana Healthcare Management fully exited Celgene Corp in Q1 2018, selling an estimated $7.83M.
  • Iguana Healthcare Management's ten largest holdings make up 38% of its $152M portfolio in Q1 2018.
  • Iguana Healthcare Management opened 25 new positions and closed 24 in Q1 2018.
  • Iguana Healthcare Management's portfolio value fell 1% quarter-over-quarter to $152M.

Based on Iguana Healthcare Management's 13F filing for Q1 2018, filed 15 May 2018.